Recurrent Implantation Failure (RIF): The Clinical Investigation Checklist

Experiencing multiple failed IVF cycles despite transferring high-quality embryos is an emotionally devastating barrier for couples. Medically, this condition is known as Recurrent Implantation Failure (RIF). When standard protocols do not result in pregnancy, a deep, systematic diagnostic review becomes vital. Prof. (Dr.) Abha Majumdar utilizes a multi-layered investigative checklist to identify hidden maternal and embryonic factors, paving a clear, predictable pathway for subsequent cycle success.

Defining RIF: When Does an IVF Failure Require Investigation?

Clinicians define RIF when a patient fails to achieve a clinical pregnancy after transferring at least three high-grade cleavage-stage embryos or two optimal blastocysts. This failure must occur across multiple fresh or frozen cycles. Consequently, repeating identical treatments without modifying diagnostic parameters rarely yields positive outcomes.

Furthermore, implantation is a complex biochemical dialogue between a competent embryo and a receptive endometrial lining. If either side displays structural or genetic irregularities, the attachment process terminates immediately. Therefore, we break our investigative framework down into distinct biological categories to isolate the root cause effectively.

Professor’s Medical Insight: Do not lose hope after failed transfers. Many patients assume their body is rejecting the baby permanently. In reality, fine-tuning the uterine microenvironment or correcting subtle blood clotting profiles frequently resolves long-standing implantation barriers.

The RIF Diagnostic Investigation Checklist

Our advanced tertiary center at Sir Ganga Ram Hospital addresses RIF through a structured, step-by-step diagnostic strategy:

Therapeutic Interventions for Subsequent Cycles

Once your checklist metrics highlight the primary biological barrier, our medical team alters subsequent treatment protocols:

• Surgical Correction: If hysteroscopy reveals an anatomical variation or localized scarring, performing precise operative resection restores normal uterine architecture instantly.
• Anticoagulant Support: Patients testing positive for clotting variations receive micro-doses of low-molecular-weight heparin (LMWH) alongside low-dose aspirin starting from the embryo transfer day.
• Extended Progesterone Alignment: If your molecular ERA analysis shows a pre-receptive lining, we precisely recalibrate the hours of hormonal priming before attempting a transfer.

Endometrial Receptivity Analysis (ERA): Finding the Implantation Window

Achieving a successful IVF pregnancy requires two essential components: a genetically healthy embryo and a receptive uterine lining. Frequently, transfer cycles fail despite using high-grade blastocysts. To resolve this clinical barrier, Prof. (Dr.) Abha Majumdar utilizes Endometrial Receptivity Analysis (ERA). This advanced molecular diagnostic tool maps the exact timeline when your uterus is ready to accept an embryo, maximizing your transfer success.

The Scientific Rationale: What is the Window of Implantation?

The endometrium is a dynamic tissue layer that becomes receptive to embryo attachment for only a very brief period during the menstrual cycle. This limited timeframe is medically termed the Window of Implantation (WOI). In approximately 70% of women, this window occurs at a standard, predictable time. However, remaining populations exhibit displaced timing patterns.

Furthermore, transferring a viable embryo outside of this personalized window leads to implantation failure. An asynchronous timeline prevents the embryo from signaling the uterine wall effectively. Consequently, performing an ERA test allows clinicians to discover your exact genetic timeline before risking precious frozen embryos.

Professor’s Medical Insight: We do not recommend the ERA test as a routine screening for every first-time IVF patient. Instead, we save this advanced tool for couples facing Recurrent Implantation Failure (RIF). Identifying a displaced window saves emotional stress and optimizes subsequent frozen cycles.

How Does the ERA Test Protocol Work?

The ERA procedure mimics an actual Frozen Embryo Transfer (FET) cycle, but without placing a real embryo inside the womb. The entire process follows a strict diagnostic sequence:

If the final molecular report marks the tissue as Non-Receptive, the system identifies the shift direction. The results will indicate whether the window is pre-receptive or post-receptive. Therefore, our medical team shifts the timing of your progesterone administration forward or backward for your actual transfer.

Who Should Undergo ERA Testing?

Because the test requires an invasive biopsy and additional laboratory costs, we apply strict selection criteria. Specifically, the ERA test provides the highest diagnostic value for the following patient profiles:

• Recurrent Implantation Failure (RIF): Patients who have experienced two or more failed transfers using morphologically excellent, high-grade blastocysts.
• Unexplained IVF Failure: Couples where both the paternal sperm parameters and maternal egg factors appear optimal, yet conception fails to occur.
• Limited Embryo Reserves: Patients with a low ovarian reserve who possess only one or two viable embryos left, requiring maximum safety parameters.

Clinical Outcomes: Personalized Embryo Transfer (pET)

Once the ERA laboratory delivers your custom timing metrics, we transition to a Personalized Embryo Transfer (pET). This protocol adjusts your medication schedule to match your unique genetic window precisely. Clinical data confirms that aligning the transfer timing significantly elevates live birth rates in patients with previous failures.

Ultimately, advanced reproductive diagnostics remove guesswork from the implantation process. By combining state-of-the-art genetic sequencing with compassionate clinical management, we help you navigate complex fertility challenges safely and predictably.